We are live on
!
Find out more
Oric Pharmaceuticals
ORIC
ORIC
164 hedge funds and large institutions have $980M invested in Oric Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 34 funds opening new positions, 68 increasing their positions, 34 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
184% more call options, than puts
Call options by funds: $383K | Put options by funds: $135K
100% more repeat investments, than reductions
Existing positions increased: 68 | Existing positions reduced: 34
62% more first-time investments, than exits
New positions opened: 34 | Existing positions closed: 21
13.21% more ownership
Funds ownership: 109.65% → 122.86% (+13%)
8% more funds holding
Funds holding: 152 → 164 (+12)
23% less capital invested
Capital invested by funds: $1.28B → $980M (-$298M)
40% less funds holding in top 10
Funds holding in top 10: 10 → 6 (-4)
Holders
164
Holders Change
+12
Holders Change %
+7.89%
% of All Funds
1.99%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
34
Increased
68
Reduced
34
Closed
21
Calls
$383K
Puts
$135K
Net Calls
+$248K
Net Calls Change
+$1.98M
Top Buyers
| 1 |
PBA
Paradigm Biocapital Advisors
New York
|
+$27.6M |
| 2 |
State Street
Boston,
Massachusetts
|
+$21.3M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$14.2M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$13.9M |
| 5 |
Goldman Sachs
New York
|
+$11.9M |
Top Sellers
| 1 |
VC
Vivo Capital
Palo Alto,
California
|
-$11.6M |
| 2 |
VA
VR Adviser
New York
|
-$10.6M |
| 3 |
SCM
Silverarc Capital Management
Boston,
Massachusetts
|
-$9.58M |
| 4 |
JP Morgan Chase
New York
|
-$9.37M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
-$6.55M |
